The week in health tech, explained in plain English.Get the free newsletter →
October 29, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Payer CEOs Sharpen Attacks on No Surprises Arbitration

Health insurance executives are turning up the volume against the No Surprises Act's arbitration system, known as independent dispute resolution, or IDR. On Cigna's second-quarter earnings call July 30, President and CEO Brian Evanko said the company backs the law's goal of shielding consumers from surprise medical bills but sees the arbitration mechanism being misused in practice, according to Becker's Hospital Review.

"We're seeing some clear abuses of the IDR vehicle in practice," Evanko said. His comments add to a growing chorus of payer leaders framing IDR as a driver of higher out-of-network payouts rather than a narrow backstop for genuine billing disputes.

The 2020 law created IDR so insurers and providers could settle out-of-network payment fights through a neutral arbiter, keeping patients out of the middle. But case volume has vastly exceeded federal projections, and providers, backed by favorable court rulings, have won a large share of disputes. The escalating rhetoric signals payers will keep pressing regulators and courts to tighten how the process works.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.